pCAG-Oct3/4-IRES-Neo Citations (3)

Originally described in: Fbx15 is a novel target of Oct3/4 but is dispensable for embryonic stem cell self-renewal and mouse development.
Tokuzawa Y, Kaiho E, Maruyama M, Takahashi K, Mitsui K, Maeda M, Niwa H, Yamanaka S Mol Cell Biol. 2003 Apr . 23(8):2699-708. PubMed Journal

---

Articles Citing pCAG-Oct3/4-IRES-Neo

Articles
Lung cancer deficient in the tumor suppressor GATA4 is sensitive to TGFBR1 inhibition. Gao L, Hu Y, Tian Y, Fan Z, Wang K, Li H, Zhou Q, Zeng G, Hu X, Yu L, Zhou S, Tong X, Huang H, Chen H, Liu Q, Liu W, Zhang G, Zeng M, Zhou G, He Q, Ji H, Chen L. Nat Commun. 2019 Apr 10;10(1):1665. doi: 10.1038/s41467-019-09295-7. PubMed
Porcine Beta-Defensin 2 Provides Protection Against Bacterial Infection by a Direct Bactericidal Activity and Alleviates Inflammation via Interference With the TLR4/NF-kappaB Pathway. Huang C, Yang X, Huang J, Liu X, Yang X, Jin H, Huang Q, Li L, Zhou R. Front Immunol. 2019 Jul 18;10:1673. doi: 10.3389/fimmu.2019.01673. eCollection 2019. PubMed
Blocking interaction between SHP2 and PD-1 denotes a novel opportunity for developing PD-1 inhibitors. Fan Z, Tian Y, Chen Z, Liu L, Zhou Q, He J, Coleman J, Dong C, Li N, Huang J, Xu C, Zhang Z, Gao S, Zhou P, Ding K, Chen L. EMBO Mol Med. 2020 Jun 8;12(6):e11571. doi: 10.15252/emmm.201911571. Epub 2020 May 11. PubMed

If you have published an article using this material, please email us at to have your article added to this page.